Detail Article

Informations générales (source: ClinicalTrials.gov)

Numéro NCT

NCT04209491 Statut inconnu

Titre

"Pilot Study: Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway in the Management of a Patient Treated for Hepatocellular Carcinoma (HCC)" (INFIC)

Type

Observational

Pathologie

Carcinomes
Carcinome hépatocellulaire

Phase

Promoteur

Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)

Date de début

septembre 2019

Date de fin

février 2020

Dernière mise à jour

29 juin 2024

Résumé

This project is based on the assumption that the nurse coordinators of the centres have common missions at each of the key stages of patient care. These missions make the care plan more fluid and improve the quality and safety of care as well as the patient's prognosis. The Hypothesis is that co-follow-up by a doctor and a nurse coordinator reduces time between referral to treatment, average lengths of stay, unscheduled readmissions or early emergency visits, compared to follow-up that does not involve a nurse coordinator.

Détail

Voir le détail Main objective: Describe the roles and missions of professionals dedicated to the coordination of care pathways for patients with HCC Secondary objectives: Compare the indicators of quality of care in HCC centres with a nurse coordinator: 1. Timeframe in treatment: - timeframe between the first contact with the HCC centre and the first interventional radiology treatment. - timeframe between the first contact with the centre and the first presentation at a multidisciplinary team meeting (MDT) - time between the first contact with the centre and the diagnostic consultation - timeframe between the first contact with the centre and discharge from the hospital - timeframe between the first interventional radiology procedure and the next for the subgroup of patients who have multiple procedures during the follow-up period - timeframe between the first contact with the nurse coordinator of the centre and discharge from the hospital. 2. The average length of stay of hospitalization 3. The number of visits to the emergency unit during the first month following the radiology intervention 4. The number of unscheduled readmissions during the first month following the intervention. Assess the feasibility of collecting the above-mentioned timeframe and variables and the patients and carers feedback on the coordination of the care pathway Describe the organization of care pathways for patients with HCC in centres with or without a nurse coordinator. Research method: This is a retrospective descriptive pilot study. It aims to describe the organization of care. Population: Patient with a diagnosis of localized hepatocellular carcinoma. Data processing: - Feasibility questionnaires will be sent by email. - The interviews will be transcribed and coded with NVivo® software - Patient data will be collected in the ecrf - Data processing from anonymized files by the authors of the research only. All data will be centralized at Bichat Hospital (URC Paris Nord) for statistical analysis. Fermer le détail

Etablissements

Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
EFS IDF SITE BEAUJON	Mohamed BOUATTOUR, MD	En recrutement IDF		Contact (sur clinicalTrials)

Critères

Genre

Tous

Nombre d'inclusion

Critère d'inclusion

Inclusion Criteria:

- Centre with interventional radiology treatment

- Active list of patients followed for a HCC of at least 70 / year

- Reply to the feasibility questionnaire within 60 days from receipt of the email

Critère de non inclusion

- Patient with a localized HCC diagnosis (BCLC A or B)

- Hospitalised for a first interventional radiology treatment (radioembolisation,
transarterial chemoembolization or percutaneous ablation) in one of the centres
included in the study between July 1, 2017 and December 31, 2017

NCT04209491 - "Pilot Study: Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway in the Management of a Patient Treated for Hepatocellular Carcinoma (HCC)" (INFIC)

Informations générales
Etablissements
Critères
Accès à la fiche NCT

Retour en haut